FDA OKs 1st Biosimilar to Prevent Chemo-Related Infections
Fulphila, biosimilar to Neulasta, helps reduce risk of infection during cancer treatment
FDA: Opioid Antidote Naloxone Recalled
Two lots of Naloxone recalled due to potential presence of particulate matter in syringe plunger
ASCO: Endocrine Tx Noninferior for HR+, HER2− Breast Cancer
Similar efficacy for endocrine, chemoendocrine tx for women with midrange 21-gene recurrence score
ASCO: mFOLFIRINOX Improves Survival in Pancreatic Cancer
And, pre-op chemoradiotherapy linked to longer overall survival than immediate surgery
Benefit of Liposomal Bupivacaine for Pain in TKA Questioned
No clinically relevant reduction in inpatient opioid use, costs for patients undergoing total knee arthroplasty
Few High-Risk Mothers in Boston Took Folic Acid Before Pregnancy
Group was mostly low-income, minority; one-third had too-low or too-high plasma folate levels
Case Shows Biotin Can Interfere With Multiple Endocrine Tests
48-year-old woman taking biotin had abnormal results for multiple tests, including total testosterone
ASCO: Pembrolizumab Superior for Initial Tx of Advanced NSCLC
Improved overall survival versus chemotherapy regardless of the PD-L1 tumor proportion score
No New Adverse Events Reported for DTaP Vaccination
Most frequently reported adverse events included injection site erythema and swelling, pyrexia
ASCO: Sunitinib Alone Noninferior in Metastatic Renal Cell Cancer
Sunitinib alone noninferior to nephrectomy plus sunitinib with respect to overall survival
